Characterization of solvents and optimization of stability and solubility of bioactive compounds used in lymphoma cell culture treatments by Adilovic, Ada et al.
Periodicals of Engineering and Natural Sciences  ISSN 2303-4521 





Characterization of solvents and optimization of stability and solubility 
of bioactive compounds used in lymphoma cell culture treatments 
 
Ada Adilović1, Lejla Mahmutović1, Emina Huseinbegović1, Mirza Suljagić1 
1Genetics and Bioengineering Department, International University of Sarajevo 
ABSTRACT   
Phytochemicals represent one of the rising agents in cancer research today. They are recognized as one the 
most abundant bio-active compounds found in many different sources, specifically in plants.  Their anti-
cancer effects have been frequently explored and reported in various research studies. However, the 
bioavailability and solubility of phytochemicals still represent the major issue in in vivo and in vitro 
research. This report analyses the effects of three different phytochemicals, commonly used for survival 
interference in malignant cancer clones, including thymoquinone (TQ), curcumin, and quercetin in a model 
of diffuse large B cell lymphoma (DLBCL). In order to characterize the impact of solubility of these 
compounds to their bioactivity in the DLBCL model, three different but highly widespread solvents were 
used. Determination of an optimal compound - solvent association is warranted when assessing the stability 
and activity of phytochemicals in cells. The results of this study indicate the dose-dependent decrease in 
cellular viability, including the treatments with all combinations of substances and solvents. In addition, we 
demonstrated that the choice of the solvent greatly influenced solubility and the overall effect of the 
compound in cancer cells.  
Keywords:  Phytochemicals, cell culture, solubility, solvents 
Corresponding Author: 
Mirza Suljagić, 
Genetics and Bioengineering, Faculty of Engineering and Natural Sciences 
International University of Sarajevo 
Hrasničkacesta 15, 71210 Ilidža, Bosnia 
msuljagic@ius.edu.ba 
1. Introduction 
1.1. The origin of phytochemicals 
The origin of phytochemicals (from Greek phyto, meaning "plant") can be traced back to the same origin of 
plants as well. In fact, many historical societies established their medicine and health practices on 
phytochemicals usage [1]. The most famous societies included the Chinese who have been using 
phytochemicals since 2800 BC and ancient Greece where Aristoteles and Hippocrates introduced plant 
medicine from Asia to Europe in the first century AD [2]. Fast forward to the 20th century, ever since the 
1980s scientists have been focusing on identifying different chemicals from plants which are of great interest 
to human health [2]. Phytochemicals are chemicals produced by plants via primary or secondary metabolism 
[3]. Multiple studies suggest the beneficial effects of phytochemicals including the anti-proliferative and anti-
angiogenic effects, regulation of nitric oxide, relaxation of blood vessels as well as the increase of blood flow 
[3]. Some of the notable examples of health benefits include carotenes which offer free radical protection [4], 
curcumin which blocks the carcinogens[4] and induces cell death in cancer cells as well as overall protection 
against DNA damage [3]. 
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1.2. Solubility and bioavailability of phytochemicals 
The solubility of bioactive compounds such as phytochemicals primarily depends on the solvent used as well 
as on temperature and pressure. Low aqueous solubility remains a problem for the pharmaceutical industry. It 
has been estimated that more than 40% of novel drugs developed by Big Pharma are practically insoluble in 
water. It remains a major difficulty, particularly for formulation scientists [5]. 
Another issue related to phytochemicals is its bioavailability. The term ‘bioavailability’ refers to the direct 
amount of ingested quantity of phytochemicals that can induce a beneficial effect in the target tissues[6]. The 
sole mechanism behind bioavailability is increasingly an issue in the drug development process [7]. These 
issues can be attributed to several different reasons such as various interactions between chemical and food 
components during processing, digestion, and/or absorption, etc. [7]. The most frequent causes of low oral 
bioavailability are attributed to poor solubility and low permeability. 
1.3. Phytochemicals in cancer research 
Cancer represents a group of many disorders that are predominantly based on the uncontrolled proliferation of 
mutated cells [8], an aberrant cell behavior [9]. Cancer cells multiply when regular cell proliferation signals 
are absent and cells are resistant to signals which trigger apoptosis [9]. Polyphenols have been identified as 
multi-beneficial therapeutic agents since they are known to inhibit cancer cell proliferation, modulate the 
activity of multiple cell signaling cascades, regulate the cell cycle, and platelet function[6]. These plant 
molecules, therefore, cause an overall decrease in tumor mass and also help protect the healthy cells from the 
adverse effects of usual cancer therapies [10]. A positive correlation between the intake of phytochemicals 
and disease prevention has been found to be closely related to dietary factors, approximately up to 90% at the 
highest times [11]. 
The stability of phytochemicals under certain conditions such as temperature, storage, and presence of 
supplements in culture media requires a constant update[6].Based on the wide literature review, we aimed to 
focus on three phytochemicals including thymoquinone, curcumin, and quercetin. The bioavailability of these 
substances is still under research in biomedicine and related disciplines. Association of a compound to an 
optimal solvent, in which it improves the stability of a compound, could in perspective provide more reliable 
data in cell culture models by proposing the most efficient ratio for a given compound/ solvent pair. Here we 
aimed to describe an experimental design that explores solubility and stability of chosen selected 
phytochemicals, commonly used for survival interference in malignant cancer clones. 
1.4. Thymoquinone 
Thymoquinone (TQ) is a common active biological substance of the volatile oil of black seed [12]. The 
recognized biological functions of TQ include initiation of apoptosis, cell cycle arrest, reactive oxygen species 
(ROS) generation, immune system propelling, prevention of metastatic, and control of angiogenic events. 
Moreover, TQ has been shown to lower the side effects which occur as the consequence of traditional 
anticancer therapy such as chemotherapy [12]. TQ is soluble in organic solvents at approximately 0.5 mg/ml 
in a 1:1 ratio solution of ethanol and PBS (pH 7.2) [13]. The solubility of TQ in ethanol is approximately 16 
mg/ml and in DSMO it is around 14 mg/ml [14]. For maximum solubility, TQ should firstly be dissolved in 
ethanol and then diluted with the buffer chosen in the study [14]. 
Many studies have reported the anticancer effect of TQ in different cancer models, including prostate cancer 
[15], colon cancer [16], and breast cancer [17]. Among others, TQ showed efficiency in decreasing cell 
viability in hematological malignancies including leukemia and lymphoma[18][19]. Many cell cycle assays 
usually showed inhibition of tumor cell proliferation even at the smallest dose of TQ, such as 25 μM solutions 
[13]. 
1.5. Curcumin 
Curcumin is a constituent of yellow powder extracted from the roots of Curcuma longa Linn, known as 
turmeric [20]. It is commonly found in dietary supplements, flavoring for foods, beverages, and cosmetics 
 PENVol. 8, No.4, December 2020, pp.2553-2563 
2555 
[21]. Curcumin is a natural phenolic compound, and as such is known as a potent anti-tumor agent with 
various anti-oxidant and anti-inflammatory properties [15]. Curcumin affects cancer cell proliferation by 
acting on different phases of the cell cycle and promoting apoptosis [21]. Its solubility is proposed to be 10 
mg/ml in ethanol and >11 mg/L in DSMO as well as 0.5 M in NaOH after which it is immediately diluted in 
PBS[22].   
Combinatorial treatments with curcumin and other anti-cancer drugs were discussed in many studies. For 
instance, one study described the range of curcumin concentrations 0.5- 8.0 g/day for 7 days with the addition 
of therapeutics for the treatment of breast cancer and 5 g for chronic myeloid leukemia (CML) in a 6 week 
period, including imatinib[23] or doxorubicin, a drug used for leukemia, lung, brain, prostate, ovarian and 
breast cancer [24]. This study demonstrated improved treatment efficiency upon the combination of 
doxorubicin and 4mg/kg curcumin when compared to doxorubicin alone [24]. Leukemia cells were shown to 
be highly sensitive to curcumin treatment. This is particularly important due to the fact that yearly almost 
500,000 people are diagnosed with leukemia and moiety dies at a rather quick rate [25]. Moreover, curcumin 
was found to inhibit the cancer growth rate and apoptosis in T-cell leukemia lineages by causing DNA 
damage and initiating cancer cell apoptosis [25]. 
1.6. Quercetin 
Quercetin is a plant flavanol representing the vast majority of the flavonoid group of phytochemicals. 
Commonly found in different foods such as apples, grapes, black, and green tea, it serves as a natural lining of 
protection against cancer activity [26]. Known quercetin anti-cancer effects include cell cycle arrest, and 
promoting apoptosis and autophagy [26]. In the discussion of generalized parameters of solubility, quercetin 
was found to be best dissolved in solvents of approximately 2 mg/ml concentration in ethanol and 30 mg/ml 
concentration in DMSO [27]. Most of the studies regarding quercetin are related to its antitumor activity at 
high concentrations, which usually range from 25 μM to 200 μM[28]. Research shows that peak 
concentrations of quercetin in the blood usually lead to 10-25 μM concentration [27]. Different types of 
studies also investigated the cytotoxic effects of quercetin in ovarian cancer, where it was found that quercetin 
does not harm healthy cells, and as such is toxic only to the malignant cells  [28]. In virtually all of the cancer 
cells of the ovarian lineage, there was a high level of inhibited proliferation and induced apoptosis as well as 
particularly the induced cell cycle arrest [29]. 
For the purpose of our study, we have chosen three different solvents, DMSO, PBS, and ethanol to test the 
solubility and stability of the above-mentioned phytochemicals. 
1.7. DMSO 
Dimethyl sulfoxide (DMSO) is a clear odorless liquid  [30], economically produced as a by-product of the 
paper industry [31]. It is a colorless liquid that performs as a polar solvent able to dissolve a large range of 
both polar and non-polar substances [32]. It is generally accepted that DMSO below 10% of concentration is 
considered nontoxic [33][34]. However, its cytotoxicity can vary between the cell lines, media, or incubation 
time [31]. Due to its useful and ambiguous properties, DMSO is used as a solvent in a vast majority of 
experimental studies [31]. 
1.8. PBS 
Phosphate-buffered saline (PBS) is a type of isotonic buffer, commonly used in biological research [28]. The 
mechanism behind PBS involves performing a simulation of normal human homeostatic conditions including 
osmolarity, pH, and ion concentrations. PBS has many uses in research because it is isotonic and non-toxic to 
most cells [35]. 
1.9. Ethanol 
In addition to its nature in commercial use, ethanol (EtOH) is used in the medical and research area as a 
solvent in cell culture [33]. Usually, it is necessary to be dissolved 1000 times or more in order to make viable 
concentrations used for experimental studies [33]. The solvent usage varies in each study, therefore the 
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concentrations can range from 0.01% to 5% from which the optimum solvent concentration can be found [33]. 
The general rule is using a concentration that will cause less toxicity to the cell cultures. Lower concentrations 
are always preferred, but, this is once again related to the importance of the stock concentration [33]. 
2. Material and methods 
2.1. Cell culture 
DHL-4 cell line was generously given by Eugenio Gaudio, PhD (Institute for Oncology Research, Bellinzona, 
Switzerland). Cells were cultured in RPMI- 1640 basal medium (Sigma Aldrich, USA), supplemented with 
10% Fetal Bovine Serum (FBS), 100 U/ml penicillin, 100 μg/ml streptomycin, 10 mM HEPES, 1mM sodium 
pyruvate, and 1% of non-essential amino acid α-Glutamine (Sigma Aldrich, USA). Cell culture was grown in 
suspension and maintained at optimal conditions in a humidified atmosphere (95%), 5% CO2 at 37°C. 
Mycoplasma contamination was tested in cultured cells by LookOut Mycoplasma qPCR Detection Kit (Sigma 
Aldrich, USA).  
2.2. Substances and solvents 
Thymoquinone (TQ), curcumin, and quercetin were purchased from Sigma Aldrich, USA (Table 1). Three 
concentrations of each substance were prepared using three different solvents including phosphate-buffered 
saline (PBS; Fisher Bioreagents, USA), dimethyl sulfoxide (DMSO; Sigma Aldrich, USA), and ethanol 
(EtOH; Honeywell, Germany). Prior to usage, PBS 10x was diluted in sterile dH2O to obtain 1x concentration, 
whereas DMSO and ethanol were used without dilution in dH2O. Substances were diluted in each solvent at 
the final volume of 1 ml to obtain 100 mM stock solutions.  
 
Table 1. Overview of substances 
Characteristics Thymoquinone Curcumin Quercetin 
Molecular 
Weight 
164.20 g/mol 368.38 g/mol 302.24 g/mol 
Appearance White to Dark Yellow and 
Faint Orange to Orange and 
Faint Brown to Brown and 
Orange-Brown and Brown-
Orange 
Yellow to Orange, 
powder 
Yellow, powder 
Purity (HPLC) > 98.0 % > 65 % > 95 % 
Formula C10H12O2 C21H20O6 C15H10O7 
Information obtained from Sigma Aldrich, USA. 
 
2.3. Evaluation of solution stability at different temperatures 
In order to test the stability of substances in all solvents, stock solutions were stored at different temperatures 
including 37 °C, room temperature (RT) (18-20 °C), and 4 °C for 48 hours. The formation of precipitates 
and/or crystals in solutions was followed twice in the period of 48h.   
2.4. Evaluation of solution stability in the cell culture medium 
To further test the stability of each solution, stock concentrations were diluted in RPMI-1640 basal cell culture 
medium (Sigma Aldrich, USA), supplemented as mentioned above. The solutions were left in the cell culture 
incubator at 37 °C and after 48 hours of incubation, the formation of precipitates was observed. 
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2.5. Evaluation of substances on cell metabolic activity 
Cells were plated at an optimum seeding density of 2.5x104 cells/well in triplicates in a 96-well plate and 
treated with doses of 100 mM, 50 mM, and 10 mM concentrations of TQ, curcumin, and quercetin dissolved 
in DMSO, PBS, and EtOH. Upon 48h incubation, 10 μl of Cell Counting Kit-8 (CCK-8) (Bimake, USA) was 
added to each well[36]. Plates were incubated at 37°C in a humidified atmosphere with 5% CO2 for 2-3 h. 
Cells incubated with solvents only were used as a control and RPMI-1640 (100 μl/well) was used as a blank. 
The absorbance values were measured at 450 nm and the reference wavelength 620 nm in a Multiscan FC 
microplate reader (Thermo Fisher Scientific, USA). The results are represented as a percentage relative to the 
negative control that was set as 100% of viability. Evaluation of effect was obtained by linear inhibition curve 
using Prism GraphPad software, version 8. 
2.6. Evaluation of substance on cell viability 
Cells were plated at an optimum seeding density of 2.5x104 cells/well in triplicates in a 96-well plate and 
treated with three different concentrations prepared in three solvents. Plates were incubated at 37°C in a 
humidified atmosphere with 5% CO2 for 48 h. Cells incubated with solvents only were used as a control. In 
order to confirm the effect of treatments, the trypan blue exclusion test was performed to determine the 
number of viable cells in each treated sample. Cells were mixed and stained with 0.4% filtered trypan blue 
solution (GibcoTM Life Technologies, USA) at a 1:1 ratio and counted with Countess II FL Automated Cell 
Counter (Thermo Fisher Scientific, USA). The results are represented as a percentage relative to the negative 
control that was set as 100% of viability. Evaluation of effect was obtained by linear inhibition curve using 
Prism GraphPad software, version 8. 
2.7. Statistical analysis 
Homogeneity of variances was tested by Levene’s test. Tukey’s post hoc test was performed where Levene's 
test indicated homogeneity of variances (p>0.05), whereas the Games-Howell post hoc test was used in case 
of non-homogeneity of variances (p<0.05). p<0.05 was considered as the level of statistical significance. 
Statistical analysis and graph preparation were done by GraphPad PRISM software, version 8.3. 
3. Results 
One of the primary aims of using three different stock solutions in this study is to find at which concentrations 
substances would dissolve the best in chosen solvents. As shown in Figure 1, the solubility of the tested 
substances was the most efficient in DMSO, when compared to PBS and EtOH. Furthermore, PBS has been 
evaluated as a poor solvent, being unable to dissolve any substance. TQ could not be dissolved in PBS, 
whereas quercetin formed an opaque solution with undissolved particles. TQ was completely dissolved in 
ethanol, while curcumin and quercetin formed precipitants even after vigorous mixing and vortexing.  
However, in preparation of 10 mM and 1mM stock concentrations, the smallest concentrations of 1 mMhave 
demonstrated the best solubility across all solvents in the case of curcumin and quercetin. TQ was not soluble 
in PBS at any stock concentration, while it was completely dissolved in DMSO and EtOH. 
 
Figure 1. Stock solutions at 100 mM in DMSO, PBS and EtOH. TQ – thymoquinone; CU – curcumin; Q - 
quercetin 
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3.1. Evaluation of solution stability at different temperatures 
All stock solutions were incubated at three different temperatures, 4°C, RT (18-25°C), and 37°C for 48h. 
Changes in the solubility of compounds were not observed upon different temperature conditions 
(Supplementary Table 1). The smallest concentrations were dissolved in all solvents at the RT, with an 
exception of TQ in PBS. Overall, we have noticed no difference between the highest and lowest temperatures 
of stock solutions. The solvents performed consistently across all temperatures where precipitates,non-cleared 
solutions, and non-homogeneity were present at higher and less at lower concentrations. PBS did not perform 
well at any temperature whereas DMSO was the best solvent at any temperature. EtOH dissolved substances 
at lower concentrations only across all temperatures.  
3.2. Evaluation of substances on cell viability  
Prior to the cell treatment, the stability of all 1mM stock solutions in the RPMI-1640 cell culture medium in 
the incubator for 48 h had been investigated. No precipitate or crystal formation in all substances except for 
TQ in PBS had been observed.  
After treatment with 10 mM, 50 mM, and 100 mM concentrations of substances in all three solvents, we have 
observed a dose-dependent decrease in relative cell viability (Figure 2). Since all concentrations were unique 
across the solvents that also gave us an insight into how solvents might affect cell viability. Trypan blue assay 
has shown that substances dissolved in DMSO had the strongest effect on cell viability compared to EtOH and 
PBS (Table 2). 
 
Figure 2. The cell viability analyzed by trypan blue assay after the treatment with TQ (A), Curcumin (B), and 
Quercetin (C) dissolved in DMSO, PBS, and EtOH 
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Table 2. Statistical analysis performed on trypan blue results in DHL-4 cell line after 48 h treatment 
Substance Treatment 
Adjusted p value* 
DMSO vs. PBS DMSO vs. EtOH PBS vs. EtOH 
Thymoquinone 
Control >0.9999 >0.9999 >0.9999 
10 mM <0.0001 <0.0001 <0.0001 
50 mM 0.7090 0.4233 0.1176 
100 mM 0.0267 0.0061 0.8015 
Curcumin 
Control >0.9999 >0.9999 >0.9999 
10 mM <0.0001 <0.0001 0.0005 
50 mM <0.0001 <0.0001 <0.0001 
100 mM 0.052 0.812 0.450 
Quercetin 
Control >0.9999 >0.9999 >0.9999 
10 mM 0.1113 0.1746 0.9670 
50 mM 0.5414 0.9274 0.3369 
100 mM 0.6169 0.9963 0.5664 
*p values obtained by Tukey’s post hoc test 
 
3.3. Evaluation of substances on cell metabolic activity 
To determine if substances decrease cell metabolic activity, we have performed WST-8 assay after 48h of 
incubation. As expected, in all substances dissolved in different solvents, we have observed a dose-dependent 
decrease (Figure 3). Results have indicated that treatment with substances in EtOH had a more prominent and 
significant effect (Table 3). Interestingly, we have seen that substances dissolved in PBS and DMSO had quite 
similar effects, without significant difference, except curcumin treatment at 100 mM and quercetin treatment 
at 10 mM (p<0.001 and p=0.0011, respectfully). 
 
Figure 3: The growth inhibition curve of TQ (A), Curcumin (B), and Quercetin (C) dissolved in PBS, DMSO, 
and EtOH 
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Lavene’s normality test showed that all samples were normally distributed (p>0.05), and we used the Games-
Howell post hoc test to analyze all treatments. 
 
Table 3. Statistical analysis performed on WST-8 assay in DHL-4 cell line after 48 h treatment 
Substance Treatment 
Adjusted p-value* 
DMSO vs. PBS 
DMSO vs. 
EtOH 
PBS vs. EtOH 
Thymoquinone 
Control >0.9999 >0.9999 >0.9999 
10 mM 0.8689 <0.0001 <0.0001 
50 mM 0.9885 0.0398 0.0541 
100 mM 0.9017 0.0008 0.0003 
Curcumin 
Control >0.9999 >0.9999 >0.9999 
10 mM >0.9999 0.0930 0.0930 
50 mM >0.9999 <0.0001 <0.0001 
100 mM <0.0001 0.0249 0.0070 
Quercetin 
Control >0.9999 >0.9999 >0.9999 
10 mM 0.0011 0.1851 <0.0001 
50 mM 0.6828 0.0084 0.0011 
100 mM 0.4315 0.4315 >0.9999 
*p values obtained by Tukey’s post hoc test 
4. Discussion 
This study aimed to evaluate the efficiency of each substance within a specific solvent. Generally speaking, 
EtOH was shown to be the most efficient solvent across all concentrations. However, its reaction across all 
substrates was strong, demonstrating the need for the presence of PBS or water for dilutions. 
Moreover, an important feature to consider is the effect of different storage temperatures on the solubility of 
all compounds. This further indicates that temperature has a slight or no effect on solubility when its range is 
from 4 ˚C to 37˚C. It was reported that the prolonged effects of solvents on compounds, which showed that a 
longer period of time is required for the solvents to have a great effect on the solubility of compounds [37]. 
We have previously demonstrated the importance of optimal sampling technique and choice of a sample for 
successful downstream applications [38], [39]. 
In this study, we aimed to determine the most effective concentrations of substances at which they are 
dissolved the best and have the greatest anti-tumor effects on the cancer cell line. This was elucidated by 
treating the cancer cell lines with three different concentrations of substances dissolved in different solvents. 
In this case, DMSO performed with the most desirable outcome, whilst PBS performed with unwanted 
outcomes. Other studies also showed a prominent effect of DMSO on cell lines, such as a study done by 
PolokaFerk and Barbara D., which showed inhibitory effects of DMSO on the metabolic activity of human 
melanoma cancer cell lines [40]. Others showed that the dosage of DMSO concentration had great importance 
on adverse events [41]. In terms of concentrations alone, 1mM showed the best solubility across all solvents, 
and particularly in curcumin and quercetin. Regarding the cell viability, the higher concentrations caused a 
dose-dependent decrease in cell viability. The idea that DMSO is surpassing solvent can be further supported 
by various studies done on cancer models including myeloblastic leukemia [42], glioblastoma [43], or 
myeloid leukemia [31]. Further research demonstrated that dissolving quercetin in DMSO diluted with PBS 
was more favorable compared to quercetin being dissolved in DMSO alone [23]. Likewise,  analyses 
demonstrated that it is advisable to use organic solvents such as DMSO in in vitro experiments to obtain more 
credible results, but also suggesting the mixing of different solvents in right rations for improved solubility 
[44]. 
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Finally, the results showed the lowest cell viability for the highest concentrations across all samples present 
when compared to the controls. Therefore, the results of this study indicate the dose-dependent decrease in 
cell viability, considering the treatments with all combinations of substances and solvents.  
5. Conclusion 
The present study was designed to evaluate the stability and effects of thymoquinone, curcumin, and quercetin 
dissolved in the three most commonly used solvents. Solubility of substances in DMSO, PBS, and EtOH was 
particularly emphasized. Effects of differently prepared and stored substances were reflected through the 
treatment of DLBCL cell line, as shown by the differences in cell viability and metabolic activity upon the 
treatment. As previously mentioned, DMSO was shown to be the best solvent at all concentrations of 
phytochemicals, whereas phytochemicals could not be fully dissolved in PBS. Ethanol was shown to be a 
powerful solvent for 10 mM and 1 mM concentrations, whereas at higher concentrations its potency was not 
demonstrated. Upon the treatment, a dose-dependent decrease in cell viability was consistently observed in all 
prepared solutions.DMSO, as a solvent showed the greatest effects on the reduction of cell viability when 
compared to PBS and EtOH. Future prospective studies regarding the solubility of compounds and its effect 
on intracellular interactions are required to properly select the solvent and optimize solvent-compound ratio.  
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